Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps.

Poposki JA, Klingler AI, Tan BK, Soroosh P, Banie H, Lewis G, Hulse KE, Stevens WW, Peters AT, Grammer LC, Schleimer RP, Welch KC, Smith SS, Conley DB, Raviv JR, Karras JG, Akbari O, Kern RC, Kato A.

Immun Inflamm Dis. 2017 Sep;5(3):233-243. doi: 10.1002/iid3.161. Epub 2017 Apr 19.

2.

Reflections on microRNAs in chronic pulmonary disease: looking into the miR-ror and crystal ball.

Karras JG, Sun G, Tay J, Jackson AL.

Inflamm Allergy Drug Targets. 2013 Apr;12(2):88-98. Review.

PMID:
23517647
3.

STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice.

Ernst M, Najdovska M, Grail D, Lundgren-May T, Buchert M, Tye H, Matthews VB, Armes J, Bhathal PS, Hughes NR, Marcusson EG, Karras JG, Na S, Sedgwick JD, Hertzog PJ, Jenkins BJ.

J Clin Invest. 2008 May;118(5):1727-38. doi: 10.1172/JCI34944.

4.

Interferon-gamma induces X-linked inhibitor of apoptosis-associated factor-1 and Noxa expression and potentiates human vascular smooth muscle cell apoptosis by STAT3 activation.

Bai Y, Ahmad U, Wang Y, Li JH, Choy JC, Kim RW, Kirkiles-Smith N, Maher SE, Karras JG, Bennett CF, Bothwell AL, Pober JS, Tellides G.

J Biol Chem. 2008 Mar 14;283(11):6832-42. doi: 10.1074/jbc.M706021200. Epub 2008 Jan 11.

5.

Inhaled CD86 antisense oligonucleotide suppresses pulmonary inflammation and airway hyper-responsiveness in allergic mice.

Crosby JR, Guha M, Tung D, Miller DA, Bender B, Condon TP, York-DeFalco C, Geary RS, Monia BP, Karras JG, Gregory SA.

J Pharmacol Exp Ther. 2007 Jun;321(3):938-46. Epub 2007 Mar 26.

6.
7.

Anti-inflammatory activity of inhaled IL-4 receptor-alpha antisense oligonucleotide in mice.

Karras JG, Crosby JR, Guha M, Tung D, Miller DA, Gaarde WA, Geary RS, Monia BP, Gregory SA.

Am J Respir Cell Mol Biol. 2007 Mar;36(3):276-85. Epub 2006 Sep 21.

PMID:
16990616
8.

Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target.

Chiarle R, Simmons WJ, Cai H, Dhall G, Zamo A, Raz R, Karras JG, Levy DE, Inghirami G.

Nat Med. 2005 Jun;11(6):623-9. Epub 2005 May 15.

PMID:
15895073
9.

Dermal delivery of topically applied oligonucleotides via follicular transport in mouse skin.

Dokka S, Cooper SR, Kelly S, Hardee GE, Karras JG.

J Invest Dermatol. 2005 May;124(5):971-5.

10.

Inhaled p38alpha mitogen-activated protein kinase antisense oligonucleotide attenuates asthma in mice.

Duan W, Chan JH, McKay K, Crosby JR, Choo HH, Leung BP, Karras JG, Wong WS.

Am J Respir Crit Care Med. 2005 Mar 15;171(6):571-8. Epub 2004 Nov 19.

PMID:
15557129
11.
12.

Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.

Song L, Turkson J, Karras JG, Jove R, Haura EB.

Oncogene. 2003 Jul 3;22(27):4150-65.

PMID:
12833138
13.

Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1.

Pedersen IM, Kitada S, Leoni LM, Zapata JM, Karras JG, Tsukada N, Kipps TJ, Choi YS, Bennett F, Reed JC.

Blood. 2002 Sep 1;100(5):1795-801.

14.

Peptide nucleic acids are potent modulators of endogenous pre-mRNA splicing of the murine interleukin-5 receptor-alpha chain.

Karras JG, Maier MA, Lu T, Watt A, Manoharan M.

Biochemistry. 2001 Jul 3;40(26):7853-9.

PMID:
11425312
15.

In vitro and in vivo inhibition of interleukin (IL)-5-mediated eosinopoiesis by murine IL-5Ralpha antisense oligonucleotide.

Lach-Trifilieff E, McKay RA, Monia BP, Karras JG, Walker C.

Am J Respir Cell Mol Biol. 2001 Feb;24(2):116-22.

PMID:
11159044
16.
18.

STAT3 regulates the growth and immunoglobulin production of BCL(1) B cell lymphoma through control of cell cycle progression.

Karras JG, McKay RA, Lu T, Pych J, Frank DA, Rothstein TL, Monia BP.

Cell Immunol. 2000 Jun 15;202(2):124-35.

PMID:
10896772
19.

Inhibition of antigen-induced eosinophilia and late phase airway hyperresponsiveness by an IL-5 antisense oligonucleotide in mouse models of asthma.

Karras JG, McGraw K, McKay RA, Cooper SR, Lerner D, Lu T, Walker C, Dean NM, Monia BP.

J Immunol. 2000 May 15;164(10):5409-15.

20.
21.

Unmethylated CpG motifs protect murine B lymphocytes against Fas-mediated apoptosis.

Wang Z, Karras JG, Colarusso TP, Foote LC, Rothstein TL.

Cell Immunol. 1997 Sep 15;180(2):162-7.

PMID:
9341746
23.

Delayed tyrosine phosphorylation and nuclear expression of STAT1 following antigen receptor stimulation of B lymphocytes.

Karras JG, Huo L, Wang Z, Frank DA, Zimmet JM, Rothstein TL.

J Immunol. 1996 Sep 15;157(6):2299-309.

PMID:
8805627
24.
25.
26.

Molecular mechanisms of toxicant-induced immunosuppression: role of second messengers.

Holsapple MP, Karras JG, Ledbetter JA, Schieven GL, Burchiel SW, Davila DR, Schatz AR, Kaminski NE.

Annu Rev Pharmacol Toxicol. 1996;36:131-59. Review.

PMID:
8725385
27.

Induction of bcl-x by CD40 engagement rescues sIg-induced apoptosis in murine B cells.

Wang Z, Karras JG, Howard RG, Rothstein TL.

J Immunol. 1995 Oct 15;155(8):3722-5.

PMID:
7561075
28.

Induction of the transcription factors NF-kappa B, AP-1 and NF-AT during B cell stimulation through the CD40 receptor.

Francis DA, Karras JG, Ke XY, Sen R, Rothstein TL.

Int Immunol. 1995 Feb;7(2):151-61.

PMID:
7537532
29.

Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on interleukin-4-mediated mechanisms of immunity.

Karras JG, Conrad DH, Holsapple MP.

Toxicol Lett. 1995 Jan;75(1-3):225-33.

PMID:
7863531
30.

Inhibition of calcium-dependent B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Karras JG, Holsapple MP.

Toxicol Appl Pharmacol. 1994 Apr;125(2):264-70.

PMID:
8171434
31.

Serum modulation of the effects of TCDD on the in vitro antibody response and on enzyme induction in primary hepatocytes.

Morris DL, Jeong HG, Stevens WD, Chun YJ, Karras JG, Holsapple MP.

Immunopharmacology. 1994 Mar-Apr;27(2):93-105.

PMID:
8014031
32.
33.
34.

Integration of the human lymphocyte into immunotoxicological investigations.

Wood SC, Karras JG, Holsapple MP.

Fundam Appl Toxicol. 1992 Apr;18(3):450-9.

PMID:
1597269
35.

Tolerance to a self peptide from the third hypervariable region of the Es beta chain. Implications for molecular mimicry models of autoimmune disease.

Roudier J, Sette A, Lamont A, Albani S, Karras JG, Carson DA.

Eur J Immunol. 1991 Sep;21(9):2063-7.

PMID:
1889457
36.

Absence of methylthioadenosine phosphorylase in human gliomas.

Nobori T, Karras JG, Della Ragione F, Waltz TA, Chen PP, Carson DA.

Cancer Res. 1991 Jun 15;51(12):3193-7.

37.
38.

Delineation of a cross-reactive idiotype on human autoantibodies with antibody against a synthetic peptide.

Chen PP, Fong S, Normansell D, Houghten RA, Karras JG, Vaughan JH, Carson DA.

J Exp Med. 1984 May 1;159(5):1502-11.

Supplemental Content

Loading ...
Support Center